0001127602-18-010264.txt : 20180305
0001127602-18-010264.hdr.sgml : 20180305
20180305204231
ACCESSION NUMBER: 0001127602-18-010264
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180301
FILED AS OF DATE: 20180305
DATE AS OF CHANGE: 20180305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOORE NICHOLAS G
CENTRAL INDEX KEY: 0001216923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 18668392
MAIL ADDRESS:
STREET 1: 495 EAST JAVA DRIVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-03-01
0000882095
GILEAD SCIENCES INC
GILD
0001216923
MOORE NICHOLAS G
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
Common Stock
2018-03-01
4
M
0
178
0
A
12233
D
Phantom Stock
0
2018-03-01
4
M
0
178
0
D
Common Stock
178
27170
D
Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.
An aggregate of 178.180639 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.180639 was paid out in cash in connection with the conversion into shares of common stock.
The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.
/s/ Marissa Song by Power of Attorney for Nicholas G. Moore
2018-03-05